Clinical trials
Recruiting Diabetic Retinopathy trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Qilu Hospital of Shandong University | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | 1 |
| Xuxiang Zhang, MD | 1 |
| Yufan Wang | 1 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Retinopathy | 7 |
| Diabetes Mellitus, Type 2 | 3 |
| Macular Edema | 2 |
| Choroidal Neovascularization | 1 |
| Diabetes Mellitus | 1 |
| Glaucoma, Neovascular | 1 |
| Macular Degeneration | 1 |
| Retinal Vein Occlusion | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.